What should you know about female viagra?

Pharmacology

After men take Viagra, the blood flowing to the sexual organs in the body will increase, which helps men to improve their sexual performance, and men only need to take Viagra in a short time before sexual behavior.

In contrast, flurbanine directly affects not the female sex organs, but her brain. It changes the levels of neurotransmitters associated with mood and satisfaction, such as dopamine and serotonin, and increases female sexual desire through complex mechanisms. The effect is not immediate, and it takes a while to appear.

According to the recommendations of the US FDA, the applicable population of flurbine is a woman who has not had menopause and has dysfunctional libido. According to a survey cited by its manufacturer, Sprout Pharmaceuticals, about 5.5 to 8.6 million women in the United States suffer from this disease, which is about 8% to 14% of women aged 20 to 49 in the United States.

Since many factors may affect sexual desire, doctors must eliminate emotional factors, other diseases, and side effects such as drug side effects when diagnosing patients with dysfunctional libido.

Effects

Flubensin has been controversial in the United States since its inception. On the one hand, its proponents believe that women need an FDA-approved drug for libido because it is a serious disease. But people who stand on the opposite side think that the risk of side effects of flurbin is too high, and some people think that sexual desire disorder is not a disease.
In 2010 and 2013, the FDA refused to approve its listing because of its unclear efficacy and side effects. For this reason, Sprout Pharmaceuticals has attracted a lot of politicians and women’s rights to lobby the FDA, and finally Addyi is allowed to go public.

According to the experimental data of Sprout Pharmaceuticals, the number of sexual behaviors that are satisfactory every month has been improved by female testers who started taking Fluboxetine. Their responses to various questionnaires showed that their sexual desires were slightly improved and the pressure was slightly reduced. Although the FDA believes that the efficacy of flurbinerine is general, it has reached its set of pharmacodynamic standards.

In the Sprout Pharmaceuticals study, approximately 10% of female test subjects experienced symptoms of dizziness, fatigue, and nausea after taking flambacine; if taken with alcoholic or antifungal drugs, it may Causes hypotension and syncope.